NGM BIOPHARMACEUTICALS INC: cashflow_operating
| Value | {"amount": -83496000, "concept": "us-gaap:NetCashProvidedByUsedInOperatingActivities", "currency": "USD"} |
|---|---|
| Period | 2020-01-01 – 2020-12-31 |
| Status | current |
| Entity | NGM BIOPHARMACEUTICALS INC |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T14:00:53.965828+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/53cea0b7-6dfa-4bf1-9730-2540048bb613
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001564590-21-013179 · Open the official SEC filing →Retrieved: 2026-08-19T14:00:53.965828+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001426332/cashflow-operating/2020-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/53cea0b7-6dfa-4bf1-9730-2540048bb613
History
- no predecessors — first report